Abstract
PIM1 is a constitutively active serine/threonine kinase regulated by cytokines, growth factors and hormones. It has been implicated in the control of cell cycle progression and apoptosis and its overexpression has been associated with various kinds of lymphoid and hematopoietic malignancies. The activity of PIM1 is dependent on the phosphorylation of several targets involved in transcription, cell cycle and apoptosis. We have recently observed that PIM1 interacts with ribosomal protein (RP)S19 and cosediments with ribosomes. Defects in ribosome synthesis (ribosomal stress) have been shown to activate a p53-dependent growth arrest response. To investigate if PIM1 could have a role in the response to ribosomal stress, we induced ribosome synthesis alterations in TF-1 and K562 erythroid cell lines. We found that RP deficiency, induced by RNA interference or treatment with inhibitor of nucleolar functions, causes a drastic destabilization of PIM1. The lower level of PIM1 induces an increase in the cell cycle inhibitor p27Kip1 and blocks cell proliferation even in the absence of p53. Notably, restoring PIM1 level by transfection causes a recovery of cell growth. Our data indicate that PIM1 may act as a sensor for ribosomal stress independently of or in concert with the known p53-dependent mechanisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA et al. (2007). Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 26: 759–772.
Bachmann M, Moroy T . (2005). The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 37: 726–730.
Badhai J, Frojmark AS, Razzaghian HR, Davey E, Schuster J, Dahl N . (2009). Posttranscriptional down-regulation of small ribosomal subunit proteins correlates with reduction of 18S rRNA in RPS19 deficiency. FEBS Lett 583: 2049–2053.
Caldarola S, De Stefano MC, Amaldi F, Loreni F . (2009). Synthesis and function of ribosomal proteins—fading models and new perspectives. FEBS J 276: 3199–3210.
Chiocchetti A, Gibello L, Carando A, Aspesi A, Secco P, Garelli E et al. (2005). Interactions between RPS19, mutated in Diamond–Blackfan anemia, and the PIM-1 oncoprotein. Haematologica 90: 1453–1462.
Danilova N, Sakamoto KM, Lin S . (2008). Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 112: 5228–5237.
Fatica A, Tollervey D . (2002). Making ribosomes. Curr Opin Cell Biol 14: 313–318.
Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J et al. (2009). Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 11: 501–508.
Hammerman PS, Fox CJ, Birnbaum MJ, Thompson CB . (2005). Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood 105: 4477–4483.
Idol RA, Robledo S, Du HY, Crimmins DL, Wilson DB, Ladenson JH et al. (2007). Cells depleted for RPS19, a protein associated with Diamond–Blackfan anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 39: 35–43.
Laird PW, van der Lugt NM, Clarke A, Domen J, Linders K, McWhir J et al. (1993). In vivo analysis of Pim-1 deficiency. Nucleic Acids Res 21: 4750–4755.
Larrea MD, Wander SA, Slingerland JM . (2009). p27 as Jekyll and Hyde: regulation of cell cycle and cell motility. Cell Cycle 8: 3455–3461.
Liu JM, Ellis SR . (2006). Ribosomes and marrow failure: coincidental association or molecular paradigm? Blood 107: 4583–4588.
Losman JA, Chen XP, Vuong BQ, Fay S, Rothman PB . (2003). Protein phosphatase 2A regulates the stability of Pim protein kinases. J Biol Chem 278: 4800–4805.
Mayer C, Grummt I . (2005). Cellular stress and nucleolar function. Cell Cycle 4: 1036–1038.
McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ et al. (2008). Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 40: 963–970.
Miyake K, Flygare J, Kiefer T, Utsugisawa T, Richter J, Ma Z et al. (2005). Development of cellular models for ribosomal protein S19 (RPS19)-deficient Diamond–Blackfan anemia using inducible expression of siRNA against RPS19. Mol Ther 11: 627–637.
Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N . (2008). Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res 68: 5076–5085.
Orru S, Aspesi A, Armiraglio M, Caterino M, Loreni F, Ruoppolo M et al. (2007). Analysis of the ribosomal protein S19 interactome. Mol Cell Proteom 6: 382–393.
Panic L, Montagne J, Cokaric M, Volarevic S . (2007). S6-haploinsufficiency activates the p53 tumor suppressor. Cell Cycle 6: 20–24.
Pestov DG, Strezoska Z, Lau LF . (2001). Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 21: 4246–4255.
Rubbi CP, Milner J . (2003). Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 22: 6068–6077.
Ruggero D, Pandolfi PP . (2003). Does the ribosome translate cancer? Nat Rev Cancer 3: 179–192.
Selten G, Cuypers HT, Berns A . (1985). Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas. EMBO J 4: 1793–1798.
Shah N, Pang B, Yeoh KG, Thorn S, Chen CS, Lilly MB et al. (2008). Potential roles for the PIM1 kinase in human cancer—a molecular and therapeutic appraisal. Eur J Cancer 44: 2144–2151.
Shay KP, Wang Z, Xing PX, McKenzie IF, Magnuson NS . (2005). Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin–proteasome pathway. Mol Cancer Res 3: 170–181.
Soeiro I, Mohamedali A, Romanska HM, Lea NC, Child ES, Glassford J et al. (2006). p27Kip1 and p130 cooperate to regulate hematopoietic cell proliferation in vivo. Mol Cell Biol 26: 6170–6184.
Steinman RA . (2002). Cell cycle regulators and hematopoiesis. Oncogene 21: 3403–3413.
Sulic S, Panic L, Barkic M, Mercep M, Uzelac M, Volarevic S . (2005). Inactivation of S6 ribosomal protein gene in T lymphocytes activates a p53-dependent checkpoint response. Genes Dev 19: 3070–3082.
Urashima M, Teoh G, Chauhan D, Ogata A, Shirahama S, Kaihara C et al. (1998). MDM2 protein overexpression inhibits apoptosis of TF-1 granulocyte-macrophage colony-stimulating factor-dependent acute myeloblastic leukemia cells. Blood 92: 959–967.
van Lohuizen M, Verbeek S, Krimpenfort P, Domen J, Saris C, Radaszkiewicz T et al. (1989). Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 56: 673–682.
Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E et al. (2000). Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288: 2045–2047.
Wang Z, Bhattacharya N, Weaver M, Petersen K, Meyer M, Gapter L et al. (2001). Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2: 167–179.
Zippo A, De Robertis A, Serafini R, Oliviero S . (2007). PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation. Nat Cell Biol 9: 932–944.
Acknowledgements
We thank Marcello Giorgi for expert technical assistance. The financial support of Telethon, Italy (Grant No. GGP07242) is gratefully acknowledged. This work was also supported by grants from Diamond Blackfan Anemia Foundation Inc. and the Italian Ministry for University and Research (MIUR) FIRB and PRIN.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Iadevaia, V., Caldarola, S., Biondini, L. et al. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression. Oncogene 29, 5490–5499 (2010). https://doi.org/10.1038/onc.2010.279
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.279
Keywords
This article is cited by
-
RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression
Cell Death & Disease (2023)
-
Transcriptomic analysis reveals that coxsackievirus B3 Woodruff and GD strains use similar key genes to induce FoxO signaling pathway activation in HeLa cells
Archives of Virology (2022)
-
High-dose copper activates p53-independent apoptosis through the induction of nucleolar stress in human cell lines
Apoptosis (2021)
-
The ubiquitin hybrid gene UBA52 regulates ubiquitination of ribosome and sustains embryonic development
Scientific Reports (2016)
-
Depletion of ribosomal protein S19 causes a reduction of rRNA synthesis
Scientific Reports (2016)